Skip to main content

Table 1 Subject characteristics

From: Decreased response inhibition in middle-aged male patients with type 2 diabetes

 

OW patients

NW patients

OW controls

NW controls

N

16

11

11

16

Age (years)

42.9 ± 8.4

50.2 ± 7.1a, b

37.0 ± 5.4a

36.6 ± 7.9b

   Range

30-59

38-58

31-48

30-56

Education (years)

15.9 ± 1.2

16.4 ± 1.3

16.6 ± 1.1

16.8 ± 1.3

BMI (kg/m2)

29.8 ± 4.5c, d

23.4 ± 1.3a, c

27.6 ± 3.8a, e

21.7 ± 1.4d, e

Systolic blood pressure (mmHg)

131.2 ± 9.9d

129.6 ± 17.8b

122.7 ± 11.2

114.2 ± 8.9b, d

Diastolic blood pressure (mmHg)

80.6 ± 11.3

78.6 ± 8.8

82.9 ± 13.2

74.8 ± 12.2

HbA1C (%)

8.2 ± 1.6d, f

7.6 ± 1.8a, b

4.9 ± 0.2a, f

4.8 ± 0.3b, d

Plasma glucose (mmol/L)

8.4 ± 2.2d, f

7.6 ± 1.6a, b

5.4 ± 0.3a, f

5.3 ± 0.3b, d

Plasma insulin (pmol/L)

82.6 ± 70.1

44.4 ± 31.3

54.2 ± 7.6

55.6 ± 11.8

HOMA-IR

4.6 ± 4.4d

2.2 ± 1.7

1.9 ± 0.3

1.9 ± 0.4d

Plasma leptin (ng/ml)

7.14 ± 4.92c, d

2.91 ± 1.47c

5.41 ± 3.90

3.48 ± 1.55d

  1. Data are given as means ± SD. a, b, c, d, e, fThere are significant differences between the groups with the same letters by Turkey-Kramer multiple comparison tests (P < 0.05). OW, overweight; NW, normal weight.